[PDF][PDF] Guidelines for the diagnosis, treatment and prevention of leprosy

World Health Organization - 2018 - apps.who.int
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy providestate-of-the-
art knowledge and evidence on leprosy diagnosis, treatment andprevention based on a …

Drug resistance in leprosy: an update following 70 years of chemotherapy

A Aubry, PS Rosa, A Chauffour, ML Fletcher… - Infectious Diseases …, 2022 - Elsevier
Leprosy is one of the oldest infectious diseases, reported for more than 2000 years. Leprosy
elimination goal as a public health problem set by the World Health Organization, aiming for …

[HTML][HTML] Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15

E Cambau, P Saunderson, M Matsuoka, ST Cole… - Clinical Microbiology …, 2018 - Elsevier
Objectives Antimicrobial resistance (AMR) is a priority for surveillance in bacterial infections.
For leprosy, AMR has not been assessed because Mycobacterium leprae does not grow in …

Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study

SM Braet, A Jouet, A Aubry, M Van Dyck-Lippens… - The Lancet …, 2022 - thelancet.com
Background Despite strong leprosy control measures, including effective treatment, leprosy
persists in the Comoros. As of May, 2022, no resistance to anti-leprosy drugs had been …

Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon

PS Rosa, HRS D'Espindula, ACL Melo… - Clinical Infectious …, 2020 - academic.oup.com
Background Leprosy has been treated with multidrug therapy, which has been distributed for
free across the globe and regarded as highly efficient. However, the impossibility of growing …

Drug resistance (dapsone, rifampicin, ofloxacin) and resistance-related gene mutation features in leprosy patients: a systematic review and meta-analysis

X Li, G Li, J Yang, G Jin, Y Shao, Y Li, P Wei… - International Journal of …, 2022 - mdpi.com
Dapsone (DDS), Rifampicin (RIF) and Ofloxacin (OFL) are drugs recommended by the
World Health Organization (WHO) for the treatment of leprosy. In the context of leprosy …

Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns

PL Lam, KKH Lee, RSM Wong… - Critical reviews in …, 2018 - Taylor & Francis
Antimicrobial resistance of disease-related microorganisms is considered a worldwide
prevalent and serious issue which increases the failure of treatment outcomes and leads to …

World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis

M Lazo-Porras, GJ Prutsky, P Barrionuevo… - BMC infectious …, 2020 - Springer
Background To evaluate the effectiveness and safety of the World Health Organization
antibiotic regimen for the treatment of paucibacillary (PB) and multibacillary (MB) leprosy …

Vaccines for leprosy and tuberculosis: opportunities for shared research, development, and application

M Coppola, SJF van den Eeden, N Robbins… - Frontiers in …, 2018 - frontiersin.org
Tuberculosis (TB) and leprosy still represent significant public health challenges, especially
in low-and lower middle-income countries. Both poverty-related mycobacterial diseases …

Leprosy transmission in Amazonian countries: current status and future trends

R Schaub, C Avanzi, P Singh, A Paniz-Mondolfi… - Current Tropical …, 2020 - Springer
Abstract Purpose of Review Leprosy is one of the first pathologies described in the history of
mankind. However, the ecology, transmission, and pathogenicity of the incriminated bacilli …